EODData

NASDAQ, QLGN:

08 Sep 2025
LAST:

1.730

CHANGE:
 0.04
OPEN:
1.710
HIGH:
1.763
ASK:
0.000
VOLUME:
11.9K
CHG(%):
2.37
PREV:
1.690
LOW:
1.690
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
08 Sep 251.7101.7631.6901.73011.9K
05 Sep 251.6701.7701.6701.69023K
04 Sep 251.7401.7401.6601.67015.6K
03 Sep 251.7601.8651.7401.74037.6K
02 Sep 251.8201.8201.7401.79017.6K
29 Aug 251.8001.8501.7401.79022.8K
28 Aug 251.8301.8501.7501.76028.2K
27 Aug 251.8501.8601.8201.82012.3K
26 Aug 251.9001.9001.8201.8517.6K
25 Aug 251.8501.8801.8501.87510.7K

COMPANY PROFILE

Name:
About:Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was founded in 1996 and is based in Carlsbad, California.
Sector:Healthcare
Industry:Biotechnology
Address:5857 Owens Avenue, Carlsbad, CA, United States, 92008
Website:https://qlgntx.com
CUSIP:74754R103
CIK:0001460702
ISIN:US74754R1032
FIGI:BBG008D03RS4

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:0.30
Price to Book:0.41
Price to Sales:0.39
Shares:1.64M
Market Cap:2.83M

TECHNICAL INDICATORS

MA5:1.72
MA10:1.77
MA20:1.79
MA50:2.47
MA100:3.08
MA200:3.39
STO9:26.09
STO14:17.65
RSI14:30.68
WPR14:-73.91
MTM14:-0.17
ROC14:-0.09
ATR:0.08
Week High:1.86
Week Low:1.66
Month High:2.09
Month Low:1.61
Year High:6.67
Year Low:0.08

RECENT SPLITS

Date Ratio
05 Nov 20241-50
23 Nov 20221-10
26 May 20201-25
23 Mar 20181-10